Literature DB >> 32261206

Visible-light degradable polymer coated hollow mesoporous silica nanoparticles for controlled drug release and cell imaging.

Shun Yang1, Najun Li, Dongyun Chen, Xiuxiu Qi, Yujie Xu, Ying Xu, Qingfeng Xu, Hua Li, Jianmei Lu.   

Abstract

A core-shell nanocomposite based on photo-degradable polymer coated hollow mesoporous silica nanoparticles (HMS) was successfully prepared for targeted drug delivery and visible-light triggered release, as well as fluorescence cell imaging. The HMS nanoparticles were first modified by the long-chain hydrocarbon octadecyltrimethoxysilane (C18) and fluorescent agent Rhodamine B isothiocyanate (RITC), and then encapsulated by a photodegradable amphiphilic copolymer via a self-assembly process. The obtained nanocarrier showed a high drug loading content due to the hollow core and mesopores of the HMS and could target folic acid receptor over-expressed tumor cells efficiently for conjugating folic acid (FA) in the amphiphilic polymer. The drug release could be triggered by the irradiation of green light (500-540 nm) due to the photodegradation of amphiphilic copolymer coated on the HMS. Furthermore, the targeted drug delivery and controlled release processes could be tracked by fluorescence imaging for the doping of RITC on the HMS. The In vitro results suggested that a smart visible light responsive drug delivery system was successfully prepared for the potential applications of cancer diagnosis and therapy.

Entities:  

Year:  2013        PMID: 32261206     DOI: 10.1039/c3tb20922a

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  2 in total

1.  Sulfonic Acid Derivative-Modified SBA-15, PHTS and MCM-41 Mesoporous Silicas as Carriers for a New Antiplatelet Drug: Ticagrelor Adsorption and Release Studies.

Authors:  Michał Moritz; Małgorzata Geszke-Moritz
Journal:  Materials (Basel)       Date:  2020-06-29       Impact factor: 3.623

2.  Magnetic mesoporous bioactive glass for synergetic use in bone regeneration, hyperthermia treatment, and controlled drug delivery.

Authors:  Muhammad Saif Ur Rahman; Muhammad Asif Tahir; Saima Noreen; Muhammad Yasir; Ijaz Ahmad; Muhammad Bilal Khan; Khawajah Waqar Ali; Muhammad Shoaib; Ali Bahadur; Shahid Iqbal
Journal:  RSC Adv       Date:  2020-06-04       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.